PRIMROSE BIO

primrose-bio-logo

Primrose Bio is a biotech company that focuses on discovery, development, and manufacturing of new molecules. innovative therapeutics, vaccines and ingredients to aevance global health.

#People #Website #More

PRIMROSE BIO

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2023-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.primrosebio.com

Status:
Active

Total Funding:
15 M USD

Technology used in webpage:
Cloudflare Hosting


Founder


helge-zieler_image

Helge Zieler

Official Site Inspections

http://www.primrosebio.com Semrush global rank: 13.65 M Semrush visits lastest month: 75

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Primrose Bio"

About Us - Primrose Bio, Inc.

As a fully integrated CMC organization, weโ€™re suited to ensure your success. LEADERSHIP. Board & ADVISORS. Our Heritage. We have established more than 100 collaborations, working alongside a diverse range of partners from โ€ฆSee details»

Our Team - Primrose Bio, Inc.

CFO | Simon Latimer Simon oversees the finance and accounting functions at Primrose Bio. Prior to joining Primrose, he was the head of corporate development and investor relations at โ€ฆSee details»

Manufacturing Solutions for Biotherapeutics and Vaccines

Sep 3, 2024 The PeliCRM197® Carrier Protein. Produced using our Pfenex Expression Technology, PeliCRM197 is the industry leading CRM197 in the market used in conjugate โ€ฆSee details»

Primrose Bio - Crunchbase Company Profile & Funding

Primrose Bio is a biotechnology company that focuses on discovery, development, and manufacturing of new molecules.See details»

Primrose Bio - LinkedIn

Primrose Bio offers radically new products and tools that unlock unexplored possibilities for the discovery, development, and manufacturing of new molecules.See details»

Introducing Primrose Bio: Enabling Innovative Therapeutic

Sep 18, 2023 Primrose Bio combines the Function Generatorโ„ข and Pelican Expression Technology ® (formerly Pfenex Expression Technology ®) platforms of its founding companies โ€ฆSee details»

Introducing Primrose Bio: Enabling Innovative โ€ฆ

Sep 18, 2023 /PRNewswire/ -- Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing state-of-the-art discovery and production systems for...See details»

Introducing Primrose Bio: Enabling Innovative Therapeutic โ€ฆ

Sep 18, 2023 Primrose Bio's technologies have been leveraged to launch Prima RNApolsโ„ข and PeliCRM197 ®, two widely licensed manufacturing and formulation solutions for biopharma โ€ฆSee details»

Primrose Bio Announces Investment from 1315 Capital to Advance ...

Jun 18, 2024 โ€œWe are thrilled to have the support of such a high-quality organization and team at 1315 Capital who share our vision of expanding opportunities in biomanufacturing โ€ฆSee details»

Primrose Bio Announces Investment from 1315 Capital โ€ฆ

SAN DIEGO, June 17, 2024 /PRNewswire/ -- Primrose Bio, Inc. ("Primrose," the "Company"), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins ...See details»

Primrose Bio Announces Investment from 1315 Capital to Advance ...

Jun 17, 2024 โ€œWe are thrilled to have the support of such a high-quality organization and team at 1315 Capital who share our vision of expanding opportunities in biomanufacturing โ€ฆSee details»

Intravacc and Primrose Bio Announce Partnership to Enhance โ€ฆ

Mar 28, 2024 The companies will leverage their combined experience in the development of conjugate vaccines for their clientsPrimrose Bio will supply its industry-leading carrier protein, โ€ฆSee details»

Primrose Bio Announces Investment from 1315 Capital to Advance ...

Jun 17, 2024 Primrose Bio, Inc. ("Primrose," the "Company"), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in โ€ฆSee details»

Intravacc And Primrose Bio Announce Partnership To Enhance โ€ฆ

Mar 28, 2024 <p>Intravacc, a leading global contract development and manufacturing organization (CDMO) specializing in infectious disease and therapeutic vaccines, and โ€ฆSee details»

BPI News: Primrose Bio Blossoms from Pelican and Primordial โ€ฆ

Sep 20, 2023 The development of state-of-the-art discovery and production systems for protein and nucleic acid medicines is exactly where Zieler is calibrating his newly formed company, โ€ฆSee details»

Primrose Bio Announces Investment from 1315 Capital to Advance ...

Jun 17, 2024 "We are thrilled to have the support of such a high-quality organization and team at 1315 Capital who share our vision of expanding opportunities in biomanufacturing โ€ฆSee details»

Introducing Primrose Bio: Enabling Innovative Therapeutic โ€ฆ

SAN DIEGO, Sept. 18, 2023 /PRNewswire/ โ€” Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing state-of-the-art discovery and production โ€ฆSee details»

Primrose Bio Company Profile 2024: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for Primrose Bio. Use the PitchBook Platform to explore the full profile.See details»

Intravacc and Primrose Bio Announce Partnership to Enhance

Mar 28, 2024 Primrose Bio will supply its industry-leading carrier protein, PeliCRM197 ®, for vaccine development; Intravacc has IP and know-how in vaccine conjugation and โ€ฆSee details»

Primrose Bio Receives Investment from 1315 Capital - FinSMEs

Jun 18, 2024 Primrose Bio, a San Diego, CA-based company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in therapeutics โ€ฆSee details»